Sands Capital, established in 1992, is an independent, employee-owned investment management firm based in Arlington, Virginia. It specializes in growth equity investments, focusing on both public and private markets globally. The firm's investment approach is centered around rigorous, bottom-up fundamental research to identify high-quality growth businesses across various sectors, including technology, healthcare, and consumer goods. Sands Capital offers its services to a diverse range of clients, such as pension plans, endowments, foundations, and high-net-worth individuals. It operates through two affiliates: Sands Capital Management for public market investments and Sands Capital Ventures for private market investments. The firm aims to provide long-term, active investment strategies that add value and enhance clients' wealth over time.
Beta Bionics is a biotechnology company focused on developing an integrated bionic pancreas system known as the iLet. This innovative device aims to alleviate the challenges and costs associated with diabetes care by providing a dual-chamber infusion pump that delivers insulin and glucagon with precision. The iLet autonomously calculates and administers the necessary doses, enabling patients to effectively manage their blood sugar levels. The system has received breakthrough designation for all its configurations, including insulin-only, glucagon-only, and bihormonal options, and is compatible with Zealand Pharma’s dasiglucagon, a glucagon analogue known for its stability in a ready-to-use aqueous solution. Through this technology, Beta Bionics seeks to improve the quality of life for individuals living with diabetes.
Freenome
Series E in 2024
Freenome, Inc. is an artificial intelligence genomics biotech company based in South San Francisco, California, founded in 2014. The company focuses on developing accurate, accessible, and non-invasive blood tests for the early detection of cancer and treatment selection. Utilizing a proprietary multi-omics platform, Freenome employs advanced algorithms to analyze cell-free genomic data, which aids in identifying early-stage cancers and other diseases. This innovative approach aims to transform disease management by enabling timely interventions and proactive treatment strategies. In addition to its diagnostic solutions, Freenome also offers clinical research services to further advance cancer detection and management.
Gusto
Series E in 2021
Gusto is a software-as-a-service company specializing in Human Capital Management (HCM). It offers a comprehensive platform that simplifies payroll processing, benefits administration, and employee management for small businesses. Gusto’s services include payroll management, time and attendance tracking, and employee onboarding, all designed to meet the various HR needs of its clients. By providing an integrated system for managing employee benefits, including health, dental, and vision insurance, Gusto enables businesses to effectively support their workforce. This platform is aimed at streamlining administrative tasks, allowing small business owners to focus on their core operations while ensuring compliance with employment regulations.
BlackBuck
Series E in 2021
Blackbuck, founded in 2015, is a leading online platform in India that connects shippers with truck operators, transforming the logistics landscape through technology. The company focuses on streamlining the trucking process by facilitating load bookings, offering price discovery, route optimization, and in-transit tracking. This comprehensive approach not only enhances operational efficiency for shippers and truckers but also supports the livelihoods of many individuals within the transportation ecosystem. Blackbuck's commitment to reliability and efficiency has positioned it as the largest trucking network in India, backed by a strong team and notable investors. The company has received multiple accolades, including the 'Young Turks Startup of the Year' award and recognition as 'Company of the Year - Logistics' in 2018. Additionally, Blackbuck's innovative business model has been featured in a Harvard Business School case study.
Snyk
Series E in 2021
Snyk Ltd., established in 2015, specializes in a Software as a Service (SaaS) platform that enhances application security. It focuses on identifying, rectifying, and monitoring known vulnerabilities across critical components of modern applications, including code, open-source libraries, containers, and infrastructure as code. Snyk's offerings, such as Snyk Code (static application security testing), container vulnerability management, and application security management, integrate seamlessly with developers' workflows, improving security posture, productivity, and collaboration. With over 1,200 global customers, including industry leaders like Google and Salesforce, Snyk is recognized for its developer-first approach and strategic partnerships.
StockX
Series E in 2020
StockX LLC is an online marketplace founded in March 2015 and headquartered in Detroit, Michigan, that facilitates the buying and selling of limited edition and high-demand sneakers. It operates a live bid/ask platform, allowing users to anonymously engage in transactions with stock market-like visibility. The marketplace offers features such as historical price and volume metrics, real-time bids and offers, and time-stamped trades, enabling users to track their sneaker collections and compare them with others on the platform. Additionally, StockX provides in-depth market analysis and news, allowing consumers to assess the value of their products and ensuring that sellers receive fair deals.
Scopely
Series E in 2020
Scopely, Inc., established in 2011 and headquartered in Culver City, California, is a leading developer of mobile and tablet touchscreen-based games for casual and core gamers worldwide. The company creates, publishes, and live-operates immersive games, including popular franchises like "Star Trek™ Fleet Command," "MARVEL Strike Force," and "Stumble Guys." Scopely offers a range of services, such as game design, live operations, marketing, analytics, and advertising, empowering a consumer-directed gaming experience. With a diverse portfolio and a proprietary technology platform, Playgami™, Scopely has operations in multiple markets across Asia-Pacific, EMEA, and North America, employing a world-class team to create long-lasting game experiences.
DataRobot
Series E in 2019
DataRobot, Inc. is a Boston-based company that specializes in developing an automated machine learning platform aimed at empowering enterprises to construct predictive models efficiently. Its offerings include DataRobot Cloud, a cloud-based platform for predictive analytics, and DataRobot MLOps, which facilitates the deployment, monitoring, and management of machine learning models across organizations. Additionally, DataRobot Enterprise provides features tailored for large organizations, such as flexible deployment options, governance, and comprehensive support. The company's solutions cater to a diverse clientele, including business analysts, data scientists, executives, and IT professionals across various sectors such as banking, healthcare, and manufacturing. Founded in 2012, DataRobot has expanded its operations internationally, with locations in London, Paris, Kyiv, Tokyo, and Singapore, and maintains a strategic partnership with Snowflake to enhance its offerings.
908 Devices
Series E in 2019
908 Devices Inc. is a Boston-based company that specializes in the development and sale of handheld and desktop measurement devices for chemical and biochemical analysis. Founded in 2012, the company leverages mass spectrometry technology to create portable tools designed for immediate application in various fields, including life sciences research, bioprocessing, industrial biotechnology, and forensics. Its product lineup includes the MX908, a battery-powered, handheld mass spectrometry device capable of rapid analysis of unknown gas, liquid, and solid materials; the Rebel, a desktop analyzer offering real-time data on bioprocess environments; and the ZipChip, a high-resolution separation platform that enhances mass spectrometry sample analysis. 908 Devices aims to provide reliable and actionable insights in challenging environments, meeting the needs of professionals who require efficient solutions for complex analytical tasks.
BigBasket
Series E in 2018
BigBasket is an online food and grocery store that specializes in delivering personal and household necessities directly to customers' doorsteps. The company offers a user-friendly platform where customers can browse an extensive range of products, select their desired items, and schedule deliveries at their convenience. BigBasket prioritizes product quality by handpicking each item and ensuring it goes through a thorough safety packaging process before reaching the customer. By focusing on efficiency and convenience, BigBasket aims to simplify the grocery shopping experience, allowing users to shop from the comfort of their homes or offices.
BigBasket
Series E in 2017
BigBasket is an online food and grocery store that specializes in delivering personal and household necessities directly to customers' doorsteps. The company offers a user-friendly platform where customers can browse an extensive range of products, select their desired items, and schedule deliveries at their convenience. BigBasket prioritizes product quality by handpicking each item and ensuring it goes through a thorough safety packaging process before reaching the customer. By focusing on efficiency and convenience, BigBasket aims to simplify the grocery shopping experience, allowing users to shop from the comfort of their homes or offices.
Avitide
Series E in 2017
Avitide, Inc. is a company that specializes in the discovery, manufacturing, and supply of molecule-specific affinity purification solutions tailored for the biopharmaceutical industry. Founded in 2012 and based in Lebanon, New Hampshire, Avitide focuses on enhancing the purification of therapeutic proteins through its innovative affinity separation technology. This technology helps clients streamline bioprocess development timelines, mitigate program risks, and lower manufacturing costs while ensuring scalability for commercial applications. The company develops customized solutions for a variety of life-saving therapeutics, including enzymes, multi-specific antibodies, gene therapies, and vaccines. By utilizing rapid development techniques for chromatography resins, Avitide aims to improve drug safety and establish bio-similarity in its offerings.
Anaplan
Series E in 2016
Anaplan, Inc. offers a cloud-based connected planning platform that enables organizations to unify disparate data structures across various business functions, including finance, sales, supply chain, marketing, human resources, and operations. Founded in 2008 and headquartered in San Francisco, Anaplan provides its services through a subscription model, allowing users to access its platform over the Internet. The company focuses on enhancing decision-making and collaboration within organizations by delivering business planning and performance management solutions from a single hub. In addition to its core platform, Anaplan offers professional services, including consulting, implementation, training, and planning transformation advisory services. With operations in multiple countries and a network of expert partners, Anaplan supports large and fast-growing organizations in streamlining their planning processes and making informed decisions.
Modernizing Medicine
Series E in 2015
ModMed is transforming healthcare by placing doctors and patients at the center of care through an intelligent, specialty-specific cloud platform. Their specialty-specific, data-driven, and cloud-based electronic health records (EHR) and practice management (PM) systems, plus revenue cycle management (RCM) services, were built by a team including specialty physicians and practice management professionals.
Funding Circle
Series E in 2015
Funding Circle is a UK-based company established in 2010, operating an online marketplace that connects small and medium-sized businesses seeking loans with a diverse range of investors, including individuals, banks, asset management companies, and government-backed entities. The platform facilitates both unsecured and secured loans for various purposes such as business growth, working capital, asset purchase, and property development. Funding Circle also works with institutional investors on securitization programs and acts as a special purpose entity issuing debt securities. The company's mission is to provide businesses with access to finance and investors with attractive returns, fostering economic growth and job creation.
AppDynamics
Series E in 2014
AppDynamics is a software company that provides an Application Intelligence Platform. This platform enables businesses to proactively monitor, manage, and optimize complex software environments in real-time. It dynamically collects millions of performance data points across applications and infrastructure, identifies anomalies instantly, applies automatic fixes, and continuously measures business impact. The platform offers flexibility for cloud or on-premise deployment, empowering businesses to gain insights faster even in dynamic production environments. Led by a senior team with deep experience in application performance management, the company has deployed its enterprise-grade solutions at thousands of organizations worldwide.
DocuSign
Series E in 2014
DocuSign, Inc., established in 2003 and headquartered in San Francisco, specializes in cloud-based software for digital agreement processes. The company's core offering, DocuSign Agreement Cloud, enables businesses to automate and manage the entire agreement lifecycle, from preparation to execution and acting on agreements. This suite includes e-signature solutions, workflow automation, AI-driven insights, and industry-specific tools. DocuSign serves a wide range of sectors, from financial services to real estate, and caters to enterprises, small businesses, and individuals. The company also operates DocuSign Ventures, its corporate venture capital arm, investing in and partnering with startups innovating around the agreement process.
Complete Genomics
Series E in 2010
Complete Genomics specializes in high-quality, affordable DNA sequencing and analysis, facilitating large-scale research into the genetic mechanisms of drug responses and complex diseases. The company has developed a comprehensive genomics analysis platform that integrates proprietary human sequencing technology with advanced informatics and data management software. This approach ensures that customers receive ready-to-use data for genome-based research, supporting advancements in personalized medicine and broader genetic studies. By combining innovative technology with a unique market strategy, Complete Genomics aims to transform the landscape of DNA sequencing.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.